Medicis Pharmaceutical Corporation v. Lupin Ltd. et al

  1. July 25, 2011

    Lupin, Medicis Reach Deal Over Generic Solodyn

    Lupin Ltd. said Monday it had reached a deal with Medicis Pharmaceutical Corp. to make a generic version of the acne drug Solodyn and to start a development collaboration worth an initial $20 million, resolving patent litigation in Maryland federal court.

  2. February 03, 2010

    Medicis Sues Lupin To Halt Generic Acne Drug

    Skin health specialist Medicis Pharmaceutical Corp. has hauled Lupin Ltd. into court over the Indian drugmaker's plan to manufacture generic versions of all five approved dosages of acne drug Solodyn.